CHEK1 and hepatocellular carcinoma: All these results together indicate that CHEK1-hsa-mir-195-5p/hsa-mir-497-5p and GPSM2-hsa-mir-122-5p may be key pathways in mediating progression of hepatocellular carcinoma and that link to patients' prognosis.